Lewis & Vlak Recent News
McNicoll, Lewis & Vlak Maintains Aastrom Biosciences Buy, $7.50 PT
McNicoll, Lewis & Vlak Reiterates Vivus Buy, $16 PT
McNicoll, Lewis & Vlak Maintains Peregrine Pharmaceuticals Buy, PT
McNicoll, Lewis & Vlak Maintains Keryx Biopharmaceuticals Buy, $18 PT
McNicoll, Lewis & Vlak Maintains Aeterna Zentaris Buy, PT
McNicoll, Lewis & Vlak Maintains Peregrine Pharmaceuticals Buy, PT
McNicoll, Lewis & Vlak Downgrades Transcept Pharmaceuticals, Lowers PT
McNicoll, Lewis & Vlak Reiterates Affymax Buy, $12 PT
McNicoll, Lewis & Vlak Maintains Icagen Hold
McNicoll, Lewis & Vlak Reiterates Corcept Therapeutics Buy, $8 PT
McNicoll, Lewis & Vlak Reiterates Inhibitex Buy, $7 PT
McNicoll, Lewis & Vlak Reiterates Rockwell Medical Buy, $16.50 PT
McNicoll, Lewis & Vlak Lowers SuperGen PT, Maintains Buy
McNicoll, Lewis & Vlak Reiterates Vivus Buy, $16 PT
McNicoll, Lewis & Vlak Maintains SuperGen Buy, $8 PT
McNicoll, Lewis & Vlak Reiterates Alnylam Pharmaceuticals Buy, $15 PT